Long‐term safety and efficacy of lanreotide autogel in Japanese patients with neuroendocrine tumors: Final results of a phase II open‐label extension study

AIM: The aim of this study was to describe the long‐term safety and efficacy of lanreotide in Japanese patients with neuroendocrine tumors. METHODS: The final analyses of a 48‐week open‐label phase II study (n = 32) and its extension study (n = 17) were conducted. Patients received 4‐weekly subcutan...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Tetsuhide, Fujimori, Nao, Honma, Yoshitaka, Kudo, Atsushi, Hijioka, Susumu, Katsushima, Shinji, Kimura, Yasutoshi, Fukutomi, Akira, Hisamatsu, Seiichi, Nakajima, Akihiro, Shimatsu, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596629/
https://www.ncbi.nlm.nih.gov/pubmed/32757459
http://dx.doi.org/10.1111/ajco.13371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596629/
https://www.ncbi.nlm.nih.gov/pubmed/32757459
http://dx.doi.org/10.1111/ajco.13371

Ejemplares similares